ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft-versus-host-disease"

  • 2017 American Transplant Congress

    Immunoregulatory Roles of CD137 Signaling in Graft-versus-Host Disease.

    H. Cho,1,2 J. Kim,1 B. Kwon,1,3 J. Lee,1,4 K. Park.1,4

    1Biomedical Research Center, Ulsan University Hospital and School of Medicine, University of Ulsan, Ulsan, Republic of Korea; 2Departments of Surgery, Ulsan University Hospital and School of Medicine, University of Ulsan, Ulsan, Republic of Korea; 3School of Biological Sciences, University of Ulsan, Ulsan, Republic of Korea; 4Department of Internal Medicine, Ulsan University Hospital and School of Medicine, University of Ulsan, Ulsan, Republic of Korea

    CD137 functions mainly as a costimulatory molecule for T cell activation. However, its functions have been found in a variety of other immune and nonimmune…
  • 2017 American Transplant Congress

    Depletion of T-Cells from G-CSF Mobilized Human PBMC Prevents Acute GVHD in NSG Mice.

    Y. Huang, H. Xu, A. Merchak, A. Chhabra, Y. Wen, L. Kahn, S. Ildstad.

    Institute for Cellular Therapeutics, University of Louisville, Louisville, KY

    Allogeneic HSC transplantation is commonly utilized for the treatment of hematologic malignancies and autoimmune diseases. However, allogeneic HSC transplantation is limited by potential for the…
  • 2017 American Transplant Congress

    Graft-versus-Host Disease Following Deceased Donor Liver Transplant.

    K. Putchakayala, S. Skorupski, S. Farhan, M. Chaffins, S. Ilias, H. Pahari, K. Collins, S. Nagai, M. Abouljoud.

    Henry Ford Hospital, Detroit, MI

    We reviewed our institutional experience with graft-versus-host disease (GVHD) following orthotopic liver transplantation (OLT). All OLT from 10/1/2013-10/1/2016 were reviewed. Five cases of GVHD were…
  • 2017 American Transplant Congress

    Eight Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients.

    J. Leventhal,1 J. Galvin,1 J. Mathew,1 L. Gallon,1 D. Stare,1 A. Sweeney,1 J. Miller,1 M. Abecassis,1 S. Ildstad.2

    1Northwestern University, Chicago; 2U of Louisville, Louisville

    36 subjects have been transplanted in a phase 2 protocol (IDE 13947) to induce tolerance in recipients of living donor renal allografts (KTx). The protocol…
  • 2017 American Transplant Congress

    Dominant Role of Clonal Deletion in Achieving Immune Tolerance After Unrelated Cord Blood Transplantation.

    P. Szabolcs,1,2 X. Chen,1 M. Hill.1

    1BMT and Cell Therapy, Children Hospital of Pittsburgh UPMC, Pittsburgh, PA; 2Immunology, University of Pittsburgh, Pittsburgh, PA

    The mechanism of immune tolerance after successful hematopoietic stem cell transplantation is not fully understood. Both central (clonal deletion) and peripheral (anergy, Treg, Tr1) mechanisms…
  • 2017 American Transplant Congress

    Contemporary Outcomes and Risk Factors of Acute Graft-versus-Host Disease After Liver Transplant.

    J. Markus, A. Bukannan, B. Kashat, R. Salgia.

    Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI

    Introduction:Acute graft-versus-host-disease (GVHD) is a rare complication of orthotopic liver transplant (LT) that has an estimated incidence of 0.1%-2% per year. This complication of OLT…
  • 2017 American Transplant Congress

    Macrophage Specific Deletion of RhoA Inhibits Fractalkine Signaling and Abrogates Chronic Rejection of Cardiac Allograft.

    M. Kloc, Y. Liu, W. Chen, X. Li, R. Ghobrial.

    Surgery, Houston Methodist Hospital and Research Institute, Houston

    Objective. Chronic rejection of transplanted organs remains unresolved issue in organ transplantation. The chronic rejection is the most common cause of graft loss within 10…
  • 2017 American Transplant Congress

    Graft-versus-Host Disease in Intestine Transplantation.

    J. Clouse, C. Kubal, B. Ekser, J. Fridell, R. Mangus.

    Surgery, Indiana University School of Medicine, Indianapolis, IN

    PurposeThis study reports the incidence, location, and outcomes of graft-versus-host disease (GVHD) at an active intestine transplant center. Subgroup analysis is employed to assess for…
  • 2017 American Transplant Congress

    iNKT Cell Activation Plus Veto Cell Transfer Yields Complete Chimerism in a Murine Sub-Lethal Bone Marrow Transplant Model.

    R. Ishii,1 T. Hirai,1 Y. Ishii,2 M. Okumi,1 K. Tanabe.1

    1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Cluster for Industry Partnerships (CIP), RIKEN, Yokohama, Japan

    Transplant tolerance induction makes it possible to preserve functional grafts for a lifetime without immunosuppressants. We have previously established a novel method for mixed chimera…
  • 2017 American Transplant Congress

    Immune Monitoring-Guided Treatment of a Pediatric Patient with Sequential GvHD, Acute Rejection and CMV Infection Following Lung Transplantation.

    C. Falk,1 S. Nicolaus,2 M. Carsten,2 T. Igor,3 S. Wiebke,3 D. Kerstin,1 K. Jana,2 H. Gesine,2 H. Axel,3 W. Gregor.3

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; 2Department of Pediatric Pulmology, Hannover Medical School, Hannover, Deutschland, Germany; 3Department of Cardiothoracic Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Deutschland, Germany

    Background: A 17 year old patient with cystic fibrosis (HLA-A11+, CMV-) underwent bilateral sequential lung transplantation (donor: HLA-A32+, CMV+). Immunosuppression (IS) consisted of Tacrolimus, MMF…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences